WO1990007000A3 - Nucleotides codant la b1,4-galactosyltransferase humaine et leurs utilisations - Google Patents
Nucleotides codant la b1,4-galactosyltransferase humaine et leurs utilisations Download PDFInfo
- Publication number
- WO1990007000A3 WO1990007000A3 PCT/US1989/005128 US8905128W WO9007000A3 WO 1990007000 A3 WO1990007000 A3 WO 1990007000A3 US 8905128 W US8905128 W US 8905128W WO 9007000 A3 WO9007000 A3 WO 9007000A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- galactosyltransferase
- provides
- encodes
- acid sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne une séquence d'acides nucléiques isolée qui code β-1,4-galactosyltransférase humaine liée à une membrane purifiée, ou son équivalent fonctionnel. Cette invention concerne également une séquence d'acides nucléiques isolée qui code β-1,4-galactosyltransférase humaine soluble et purifiée ou son équivalent fonctionnel. L'invention concerne en outre des vecteurs comprenant ces séquences d'acides nucléiques et l'expression de protéines recombinantes par l'utilisation d'un système vecteur hôte. L'invention concerne également des anticorps réagissant avec les protéines et des sondes réagissant avec les séquences d'acides nucléiques. Finalement, l'invention décrit une méthode permettant de diagnostiquer une anémie dyserthropoiétique congénitale de type II chez un sujet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28373288A | 1988-12-13 | 1988-12-13 | |
US283,732 | 1988-12-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1990007000A2 WO1990007000A2 (fr) | 1990-06-28 |
WO1990007000A3 true WO1990007000A3 (fr) | 1990-08-09 |
Family
ID=23087318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/005128 WO1990007000A2 (fr) | 1988-12-13 | 1989-11-16 | Nucleotides codant la b1,4-galactosyltransferase humaine et leurs utilisations |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4751990A (fr) |
CA (1) | CA2003797A1 (fr) |
WO (1) | WO1990007000A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5032519A (en) * | 1989-10-24 | 1991-07-16 | The Regents Of The Univ. Of California | Method for producing secretable glycosyltransferases and other Golgi processing enzymes |
SE9201544L (sv) * | 1991-05-31 | 1992-12-01 | Ciba Geigy Ag | Saett att framstaella glykosyltransferaser |
GB2256197B (en) * | 1991-05-31 | 1995-11-22 | Ciba Geigy Ag | Yeast as host for expression of heterologous glycosyl transferase enzymes |
JPH08503373A (ja) * | 1992-11-27 | 1996-04-16 | チバ−ガイギー アクチェンゲゼルシャフト | グリコシルトランスフェラーゼ活性を有するタンパク質 |
GB9603256D0 (en) * | 1996-02-16 | 1996-04-17 | Wellcome Found | Antibodies |
US6558934B1 (en) * | 1998-07-17 | 2003-05-06 | Glycozm Aps | UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyl-transferase, β4Gal-T2 |
CA2384978C (fr) | 1999-08-24 | 2012-10-23 | Glycozym Aps | Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac - galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3 |
CN1331292A (zh) * | 2000-06-26 | 2002-01-16 | 上海博德基因开发有限公司 | 一种新的多肽——人β-1,4半乳糖苷转运酶13.2和编码这种多肽的多核苷酸 |
-
1989
- 1989-11-16 AU AU47519/90A patent/AU4751990A/en not_active Abandoned
- 1989-11-16 WO PCT/US1989/005128 patent/WO1990007000A2/fr unknown
- 1989-11-24 CA CA002003797A patent/CA2003797A1/fr not_active Abandoned
Non-Patent Citations (3)
Title |
---|
Biochemical and Biophysical Research Communications, vol. 139, no. 1, 29 August 1986, Academic Press, Inc., (Duluth, MN, US), H.E. Appert et al.: "Isolation of a cDNA coding for human galactosyl transferase", pages 163-168, see the whole article (cited in the application) * |
Biochemical and Biophysical Research Communications, vol. 187, no. 2, 15 December 1988, Academic Press, Inc., (Duluth, MN, US), K.A. Masri et al.: "Identification of the full-lenght coding sequence for human galactosyltransferase (beta-N-acetylglucosaminide: betal, 4-galactosyltransferase)", see pages 657-663 * |
The Journal of Biological Chemistry, vol. 263, no. 21, 25 July 1988, (Baltimore, ND, US), N.L. Shaper et al.: "Characterization of the full lenght cDNA for murine beta-1,4-Galactosyltransferase", pages 10420-10428, see "Discussion" (cited in the application) * |
Also Published As
Publication number | Publication date |
---|---|
CA2003797A1 (fr) | 1990-06-13 |
WO1990007000A2 (fr) | 1990-06-28 |
AU4751990A (en) | 1990-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999055868A3 (fr) | Proteines fizz | |
EP0784059A4 (fr) | Polypeptide antigenique de chlamydia pneumoniae | |
AU2705895A (en) | Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein | |
HK1013847A1 (en) | Gdf-1 and uog-1 proteins | |
WO1996034107A3 (fr) | Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations | |
EP0749442A4 (fr) | PROTEINE p27 ISOLEE ET MOLECULES D'ACIDE NUCLEIQUE CODANT CETTE PROTEINE | |
WO1999063088A8 (fr) | Proteines membranaires et acides nucleiques codant ces proteines | |
WO1999028462A3 (fr) | Polypeptides et acides nucleiques codant ces derniers | |
EP0360257A3 (fr) | ARN-catalyseur pour le clivage des séquences spécifiques d'ARN | |
WO1998018930A3 (fr) | ANTIGENES ET VACCINS ACTIFS CONTRE $i(STREPTOCOCCUS PNEUMONIAE) | |
ES8602119A1 (es) | Metodo para preparar inmunoglobulinas en celulas hospedantes recombinantes | |
WO1999061469A3 (fr) | Proteines de membrane associees a la croissance de la prostate | |
NZ502391A (en) | Mammalian cytokine: interleukin-B30 and related reagents | |
IL133056A0 (en) | A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same | |
WO1997043409A3 (fr) | Procede d'obtention de nouvelles sequences d'adn | |
EP0821064A3 (fr) | Fructosyl amino acide oxidase recombinante | |
WO1995006735A3 (fr) | Sequences nucleotidiques servant a coder de nouvelles tyrosine-phosphatases proteiques | |
AU3230797A (en) | Dna encoding dp. 75 and a process for its use | |
WO1990007000A3 (fr) | Nucleotides codant la b1,4-galactosyltransferase humaine et leurs utilisations | |
WO1995008628A3 (fr) | Acides nucleiques codant la merosine, fragments de merosine et utilisations de ceux-ci | |
WO2000059942A3 (fr) | COMPOSITIONS hOB-BP2h, LEURS TECHNIQUES ET LEURS UTILISATIONS | |
WO2002074960A3 (fr) | Methodes et compositions relatives aux proteines humaines 38650, 28472, 5495, 65507, 81588 et 14354 et leurs utilisations | |
EP0345792A3 (fr) | Protéines fusionnées HTLV-I/HIV-I | |
WO2000040607A3 (fr) | Adn codant les proteines tiam-2 et procede d'utilisation dudit adn | |
EP1241186A3 (fr) | Protéine gas-6 (growth arrest-specific gene 6) humaine et acides nucléiques le codant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE ES FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE ES FR GB IT LU NL SE |